Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Akebia Therapeutics, Inc. (AKBA) had Debt to Capital Ratio of 0.53 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$58.77M |
|
$0.54M |
|
$9.38M |
|
$49.38M |
|
$54.32M |
|
$4.45M |
|
$-3.29M |
|
$1.16M |
|
$1.16M |
|
$0.54M |
|
$0.54M |
|
$0.54M |
|
$0.54M |
|
$4.45M |
|
$4.77M |
|
264.79M |
|
274.37M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$258.34M |
|
$1.47M |
|
$105.82M |
|
$364.15M |
|
$133.38M |
|
$47.64M |
|
$189.18M |
|
$322.56M |
|
$41.59M |
|
$-17.45M |
|
$41.59M |
|
265.23M |
|
| Cash Flow Statement Financials | |
$36.86M |
|
$-0.05M |
|
$77.78M |
|
$53.55M |
|
$168.14M |
|
$114.59M |
|
$8.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.94 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.53 |
1.15 |
|
84.03% |
|
7.57% |
|
7.57% |
|
-- |
|
1.97% |
|
0.92% |
|
$36.81M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.50 |
|
0.89 |
|
101.42 |
|
1.30% |
|
-3.09% |
|
0.15% |
|
0.61% |
|
$0.16 |
|
$0.13 |
|
$0.13 |
|